(QCOM) Qualcomm - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 213.446m USD | Total Return: 44.4% in 12m
Industry Rotation: +7.3
Avg Turnover: 5.70B
EPS Trend: 93.2%
Qual. Beats: 0
Rev. Trend: 91.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Qualcomm Incorporated is a global leader in wireless technology, specializing in the development of semiconductors and intellectual property for the mobile, automotive, and IoT sectors. The company operates through three primary segments: Qualcomm CDMA Technologies (QCT), which focuses on integrated circuits and software; Qualcomm Technology Licensing (QTL), which manages an extensive portfolio of 3G, 4G, and 5G patents; and Qualcomm Strategic Initiatives (QSI), which handles venture investments in emerging tech like AI and extended reality.
The company utilizes a high-margin licensing business model where manufacturers pay royalties to use Qualcomms cellular standard-essential patents, regardless of whether they use the companys physical chips. In the semiconductor sector, Qualcomm is a fabless manufacturer, meaning it designs its hardware in-house but outsources the physical fabrication to third-party foundries to reduce capital intensity.
Investors can evaluate the long-term sustainability of these royalty streams and chip demand by reviewing the detailed financial metrics on ValueRay. Founded in 1985 and headquartered in San Diego, Qualcomm also provides specialized hardware and development services to United States government agencies.
- Handset demand recovery in China drives short-term QCT segment revenue growth
- High-margin QTL licensing revenue faces ongoing global regulatory and legal challenges
- Automotive design win pipeline expansion diversifies revenue beyond mobile handsets
- On-device AI processing capabilities accelerate premium smartphone upgrade cycles
- Geopolitical trade restrictions on high-end chip exports impact long-term China exposure
| Net Income: 9.92b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: 30.00% < 20% (prev 39.11%; Δ -9.11% < -1%) |
| CFO/TA 0.25 > 3% & CFO 14.29b > Net Income 9.92b |
| Net Debt (9.84b) to EBITDA (13.34b): 0.74 < 3 |
| Current Ratio: 2.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.07b) vs 12m ago -3.86% < -2% |
| Gross Margin: 54.80% > 18% (prev 0.56%; Δ 5.42k% > 0.5%) |
| Asset Turnover: 79.08% > 50% (prev 76.37%; Δ 2.72% > 0%) |
| Interest Coverage Ratio: 12.64 > 6 (EBITDA TTM 13.34b / Interest Expense TTM 678.0m) |
| A: 0.23 (Total Current Assets 23.11b - Total Current Liabilities 9.77b) / Total Assets 57.14b |
| B: 0.47 (Retained Earnings 26.90b / Total Assets 57.14b) |
| C: 0.15 (EBIT TTM 8.57b / Avg Total Assets 56.25b) |
| D: 0.91 (Book Value of Equity 27.28b / Total Liabilities 29.86b) |
| Altman-Z'' = 5.05 = AAA |
| DSRI: 1.12 (Receivables 4.35b/3.70b, Revenue 44.49b/42.28b) |
| GMI: 1.02 (GM 54.80% / 55.68%) |
| AQI: 1.13 (AQ_t 0.51 / AQ_t-1 0.45) |
| SGI: 1.05 (Revenue 44.49b / 42.28b) |
| TATA: -0.08 (NI 9.92b - CFO 14.29b) / TA 57.14b) |
| Beneish M = -2.88 (Cap -4..+1) = A |
Over the past week, the price has changed by +6.66%, over one month by +57.43%, over three months by +52.97% and over the past year by +44.35%.
- StrongBuy: 12
- Buy: 5
- Hold: 19
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 177.6 | -16.8% |
P/E Forward = 18.3486
P/S = 4.798
P/B = 7.5582
P/EG = 0.8333
Revenue TTM = 44.49b USD
EBIT TTM = 8.57b USD
EBITDA TTM = 13.34b USD
Long Term Debt = 14.77b USD (from longTermDebt, last quarter)
Short Term Debt = 498.0m USD (from shortTermDebt, last quarter)
Debt = 15.27b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.84b USD (from netDebt column, last quarter)
Enterprise Value = 218.92b USD (213.45b + Debt 15.27b - CCE 9.80b)
Interest Coverage Ratio = 12.64 (Ebit TTM 8.57b / Interest Expense TTM 678.0m)
EV/FCF = 17.51x (Enterprise Value 218.92b / FCF TTM 12.50b)
FCF Yield = 5.71% (FCF TTM 12.50b / Enterprise Value 218.92b)
FCF Margin = 28.10% (FCF TTM 12.50b / Revenue TTM 44.49b)
Net Margin = 22.31% (Net Income TTM 9.92b / Revenue TTM 44.49b)
Gross Margin = 54.80% ((Revenue TTM 44.49b - Cost of Revenue TTM 20.11b) / Revenue TTM)
Gross Margin QoQ = 53.77% (prev 54.55%)
Tobins Q-Ratio = 3.83 (Enterprise Value 218.92b / Total Assets 57.14b)
Interest Expense / Debt = 1.12% (Interest Expense 171.0m / Debt 15.27b)
Taxrate = 21.0% (US default 21%)
NOPAT = 6.77b (EBIT 8.57b * (1 - 21.00%))
Current Ratio = 2.37 (Total Current Assets 23.11b / Total Current Liabilities 9.77b)
Debt / Equity = 0.56 (Debt 15.27b / totalStockholderEquity, last quarter 27.28b)
Debt / EBITDA = 0.74 (Net Debt 9.84b / EBITDA 13.34b)
Debt / FCF = 0.79 (Net Debt 9.84b / FCF TTM 12.50b)
Total Stockholder Equity = 24.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.64% (Net Income 9.92b / Total Assets 57.14b)
RoE = 40.19% (Net Income TTM 9.92b / Total Stockholder Equity 24.69b)
RoCE = 21.72% (EBIT 8.57b / Capital Employed (Equity 24.69b + L.T.Debt 14.77b))
RoIC = 17.09% (NOPAT 6.77b / Invested Capital 39.61b)
WACC = 11.40% (E(213.45b)/V(228.72b) * Re(12.15%) + D(15.27b)/V(228.72b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 12.15% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.41 | Cagr: -2.20%
[DCF] Terminal Value 69.16% ; FCFF base≈12.18b ; Y1≈13.67b ; Y5≈18.24b
[DCF] Fair Price = 169.6 (EV 188.57b - Net Debt 9.84b = Equity 178.74b / Shares 1.05b; r=11.40% [WACC]; 5y FCF grow 14.09% → 3.0% )
EPS Correlation: 93.17 | EPS CAGR: 14.69% | SUE: 0.76 | # QB: 0
Revenue Correlation: 91.79 | Revenue CAGR: 9.16% | SUE: 0.06 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.23 | Chg30d=-8.50% | Revisions=-79% | Analysts=31
EPS current Year (2026-09-30): EPS=10.80 | Chg30d=-2.56% | Revisions=-75% | GrowthEPS=-10.3% | GrowthRev=-3.8%
EPS next Year (2027-09-30): EPS=10.64 | Chg30d=-3.50% | Revisions=-50% | GrowthEPS=-1.5% | GrowthRev=+0.0%
[Analyst] Revisions Ratio: -79%